Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 2Inflammation 2Stomach Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Bupivacaine 18Ropivacaine 10Saline Solution 9Dexmedetomidine 9Sodium Chloride 5Pregabalin 5Morphine 5Ketamine 5Lidocaine 4Dexamethasone 4Control Groups 4Analgesia, Patient-Controlled 4Tea 3Gabapentin 3Anesthetics, Local 3Acetaminophen 3Population Groups 2Parapsychology 2Magnesium Sulfate 2Injections, Epidural 2Fentanyl 2Dental Occlusion 2Anti-Inflammatory Agents, Non-Steroidal 2Analgesics, Opioid 2thiamine triphosphorate 1ramosetron 1parecoxib 1gamma-Aminobutyric Acid 1esmolol 1Water 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain, Postoperative × Sufentanil × Clear all
NCT04248179 2023-02-09

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Zealand University Hospital

Phase 4 Completed
36 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡